Recentes

• GMP CANÁBIS 2026 : “Formação conduzida com profundo domínio teórico e prático “
• MHRA Open consultation Draft rare disease therapies regulatory framework
• EU Delegated Acts on Well-Established Technologies (WET) under the MDR
• CLINICAL TRIALS: EMA CTIS Sponsor Handbook
• Update to EU GMP Guidelines – Revised Annex 19 on Reference and Retention Samples
• FARMACOVIGILÂNCIA nível avançado : Formação completa con casos práticos
• FDA DRAFT GUIDANCE :Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products
• European Biotech Act: Positioning EU as Biotech Powerhouse